Page last updated: 2024-09-04

vatalanib and Retinal Neovascularization

vatalanib has been researched along with Retinal Neovascularization in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bennewitz, K; Hammes, HP; Hillebrands, JL; Krenning, G; Kroll, J; Metzger, L; Poschet, G; Qi, H; Stoll, SJ; Wiggenhauser, LM1
Augustin, HG; Dietz, CT; Epting, D; Feng, Y; Hammes, HP; Kern, K; Kroll, J; Wieland, T1
Agostini, HT; Drevs, J; Hansen, LL; Junker, B; Maier, P; Martin, G; Unsoeld, AS1

Other Studies

3 other study(ies) available for vatalanib and Retinal Neovascularization

ArticleYear
Activation of Retinal Angiogenesis in Hyperglycemic
    Diabetes, 2020, Volume: 69, Issue:5

    Topics: Animals; Blood Glucose; CRISPR-Cas Systems; Gene Deletion; Gene Expression Regulation; Homeodomain Proteins; Hyperglycemia; Larva; Neovascularization, Pathologic; Nitric Oxide; Phthalazines; Protein Kinase Inhibitors; Pyridines; Retinal Neovascularization; Retinal Vessels; Trans-Activators; Vascular Endothelial Growth Factor A; Zebrafish

2020
Inhibition of Rho-dependent kinases ROCK I/II activates VEGF-driven retinal neovascularization and sprouting angiogenesis.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Animals, Newborn; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Physiologic; Oxygen; Phthalazines; Protein Kinase Inhibitors; Pyridines; Receptors, Vascular Endothelial Growth Factor; Retinal Neovascularization; rho-Associated Kinases; RNA Interference; RNA, Small Interfering; Vascular Endothelial Growth Factor A

2009
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:6

    Topics: Animals; Animals, Newborn; Disease Models, Animal; Female; Injections; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Phthalazines; Protein Kinase Inhibitors; Pyridines; Reperfusion Injury; Retinal Neovascularization; Treatment Outcome; Vitreous Body

2005